Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-21-031097

Chief Executive Officer bought 25,000 shares at $8.00 ($200,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Tak Paul Peter Chief Executive Officer 2021-07-29 Purchase +25,000 $8.00 $200,000 25,000 D
Open-market purchases · 25,000 sh · avg $8.00 · $200,000
Loading xslF345X03/doc4.xml…